Scorpius BioManufacturing is an integrated contract development and manufacturing organization (CDMO) focused on cell- and gene-based therapies and large molecule biologics. Scorpius provides a broad portfolio of analytical and biomanufacturing services that enable academic laboratories, research institutes, as well as pharmaceutical and biotech companies, to advance their discoveries and deliver new therapies to patients. Scorpius BioManufacturing offers a range of services and analytical test methods to support pre-clinical studies for large molecule product development. Their biomanufacturing services focus on accelerating product development timelines from preclinical evaluation to first-in-human studies and beyond in support of commercial manufacturing programs. By integrating analytical methods development, process development, cGMP manufacturing product characterization, and QC release testing, the company can efficiently develop a client-specific clinical manufacturing solutions that enables a faster path to clinical trials and product commercialization.